A highly significant decrease of fractional shortening (FS) (Sham: 50.86% ± 0.82% vs.
← all excerpts
Sacubitril/valsartan mitigates cardiac remodeling, systolic dysfunction, and preserves mitochondrial quality in a rat model of mitral regurgitation.
1
—
—